Correlation between Sorangium cellulosum subgroups and their potential for secondary metabolite production

J Microbiol Biotechnol. 2013 Mar;23(3):297-303. doi: 10.4014/jmb.1210.10054.

Abstract

Phylogenetic analysis of the groEL1 and xynB1 gene sequences from Sorangium cellulosum strains isolated in Korea previously revealed the existence of at least 5 subgroups (A-E). In the present study, we used sequence analysis of polymerase chain reaction-amplified biosynthetic genes of strains from the 5 subgroups to indicate correlations between S. cellulosum subgroups and their secondary metabolic gene categories. We detected putative biosynthetic genes for disorazol, epothilone, ambruticin, and soraphen in group A, group C, group D, and group E strains, respectively. With the exception of KYC3204, culture extracts from group A, group B, and group C strains exhibited no noticeable antimicrobial inhibitory activities. By contrast, culture extracts from group D strains inhibited the growth of Candida albicans, whereas culture extracts from group E strains inhibited the growth of C. albicans and Staphylococcus aureus. High performance liquid chromatography analysis of the culture extracts from the strains of each subgroup revealed unique peak patterns. Our findings indicate the existence of at least 5 subgroups of S. cellulosum strains, each of which has the potential to produce a unique set of secondary metabolites.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / analysis
  • Anti-Infective Agents / pharmacology
  • Biological Products / analysis*
  • Biological Products / pharmacology
  • Biosynthetic Pathways / genetics
  • Candida albicans / drug effects
  • Candida albicans / growth & development
  • Chaperonin 60 / genetics
  • Chromatography, High Pressure Liquid
  • Cluster Analysis
  • DNA, Bacterial / chemistry
  • DNA, Bacterial / genetics
  • Endo-1,4-beta Xylanases / genetics
  • Korea
  • Molecular Sequence Data
  • Myxococcales / classification*
  • Myxococcales / genetics
  • Myxococcales / isolation & purification
  • Myxococcales / metabolism*
  • Phylogeny
  • Polymerase Chain Reaction
  • Sequence Analysis, DNA
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / growth & development
  • beta-Glucosidase / genetics

Substances

  • Anti-Infective Agents
  • Biological Products
  • Chaperonin 60
  • DNA, Bacterial
  • beta-Glucosidase
  • Endo-1,4-beta Xylanases
  • XynB xylanase

Associated data

  • GENBANK/JN043257
  • GENBANK/JN043258
  • GENBANK/JN043259
  • GENBANK/JN043260
  • GENBANK/JN043261
  • GENBANK/JN043262
  • GENBANK/JN043263
  • GENBANK/JN043264
  • GENBANK/JN043265
  • GENBANK/JN043266
  • GENBANK/JN043267
  • GENBANK/JN043268
  • GENBANK/JN043269
  • GENBANK/JN043270
  • GENBANK/JN043271